GlobeNewswire Inc.··Celldex Therapeutics, Inc.Celldex Raises $345M in Public Offering as Underwriters Exercise Full Option
Celldex Therapeutics closed $345M public offering at $29/share with full underwriter option exercise, netting approximately $401M in total gross proceeds.
CLDXpublic offeringcommon stock